Clinical Trial Update: Pharmacological Intervention in Insulin Resistance Targeting Autonomic Nerve Activity [EARLY_Phase 1]

View source ↗

Summary

A completed early-phase 1 clinical trial sponsored by AstraZeneca investigated a pharmacological intervention for insulin resistance targeting autonomic nerve a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance

Snippet

Sponsor: AstraZeneca | Conditions: Insulin Resistance | EARLY_Phase 1 | Status: COMPLETED